156 related articles for article (PubMed ID: 8521889)
1. Extragonadal germ cell tumors: prognostic factors and long-term follow-up.
Aparicio J; Montalar J; Munárriz EB; Reynés G; Gómez-Codina J; Pastor M; Herranz C
Eur Urol; 1995; 28(1):19-24. PubMed ID: 8521889
[TBL] [Abstract][Full Text] [Related]
2. Extragonadal seminoma: an international multicenter analysis of prognostic factors and long term treatment outcome.
Bokemeyer C; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Schmoll HJ; Kanz L; Einhorn L; Nichols CR; Hartmann JT
Cancer; 2001 Apr; 91(7):1394-401. PubMed ID: 11283942
[TBL] [Abstract][Full Text] [Related]
3. Extragonadal germ cell tumors: relation to testicular neoplasia and management options.
Bokemeyer C; Hartmann JT; Fossa SD; Droz JP; Schmol HJ; Horwich A; Gerl A; Beyer J; Pont J; Kanz L; Nichols CR; Einhorn L
APMIS; 2003 Jan; 111(1):49-59; discussion 59-63. PubMed ID: 12752235
[TBL] [Abstract][Full Text] [Related]
4. Extragonadal germ cell tumors of the mediastinum and retroperitoneum: results from an international analysis.
Bokemeyer C; Nichols CR; Droz JP; Schmoll HJ; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Hartmann JT
J Clin Oncol; 2002 Apr; 20(7):1864-73. PubMed ID: 11919246
[TBL] [Abstract][Full Text] [Related]
5. Platinum-based chemotherapy of primary extragonadal germ cell tumours: the Hellenic Cooperative Oncology Group experience.
Pectasides D; Aravantinos G; Visvikis A; Bakoyiannis C; Halikia A; Kalofonos C; Kosmidis P; Skarlos D; Fountzilas G
Oncology; 1999 Jul; 57(1):1-9. PubMed ID: 10394118
[TBL] [Abstract][Full Text] [Related]
6. Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features.
Toner GC; Geller NL; Lin SY; Bosl GJ
Cancer; 1991 Apr; 67(8):2049-57. PubMed ID: 1848473
[TBL] [Abstract][Full Text] [Related]
7. Extragonadal germ cell tumors in Taiwan: an analysis of treatment results of 59 patients.
Hsu YJ; Pai L; Chen YC; Ho CL; Kao WY; Chao TY
Cancer; 2002 Aug; 95(4):766-74. PubMed ID: 12209720
[TBL] [Abstract][Full Text] [Related]
8. Extragonadal germ cell tumors. A 14-year Toronto experience.
Goss PE; Schwertfeger L; Blackstein ME; Iscoe NA; Ginsberg RJ; Simpson WJ; Jones DP; Shepherd FA
Cancer; 1994 Apr; 73(7):1971-9. PubMed ID: 8137224
[TBL] [Abstract][Full Text] [Related]
9. [Primary extragonadal germ cell tumors in man. 2. Therapy and prognosis].
von Paris V; Manke U
Z Gesamte Inn Med; 1991 Aug; 46(12):437-42. PubMed ID: 1659047
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin-based chemotherapy of primary extragonadal germ cell tumors. A single institution experience.
Gerl A; Clemm C; Lamerz R; Wilmanns W
Cancer; 1996 Feb; 77(3):526-32. PubMed ID: 8630961
[TBL] [Abstract][Full Text] [Related]
11. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
12. How to classify, diagnose, treat and follow-up extragonadal germ cell tumors? A systematic review of available evidence.
Winter C; Zengerling F; Busch J; Heinzelbecker J; Pfister D; Ruf C; Lackner J; Albers P; Kliesch S; Schmidt S; Bokemeyer C
World J Urol; 2022 Dec; 40(12):2863-2878. PubMed ID: 35554637
[TBL] [Abstract][Full Text] [Related]
13. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
Malagón HD; Valdez AM; Moran CA; Suster S
Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes for men with mediastinal germ-cell tumors: the University of Texas M. D. Anderson Cancer Center experience.
Rodney AJ; Tannir NM; Siefker-Radtke AO; Liu P; Walsh GL; Millikan RE; Swisher SG; Tu SM; Pagliaro LC
Urol Oncol; 2012; 30(6):879-85. PubMed ID: 20933444
[TBL] [Abstract][Full Text] [Related]
15. Extragonadal germ cell tumor: a clinical study.
Bassetto MA; Pasini F; Franceschi T; Mustacchi G; Cetto GL
Anticancer Res; 1995; 15(6B):2751-4. PubMed ID: 8669858
[TBL] [Abstract][Full Text] [Related]
16. Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience.
De Giorgi U; Demirer T; Wandt H; Taverna C; Siegert W; Bornhauser M; Kozak T; Papiani G; Ballardini M; Rosti G;
Ann Oncol; 2005 Jan; 16(1):146-51. PubMed ID: 15598952
[TBL] [Abstract][Full Text] [Related]
17. Prognostic variables for response and outcome in patients with extragonadal germ-cell tumors.
Hartmann JT; Nichols CR; Droz JP; Horwich A; Gerl A; Fossa SD; Beyer J; Pont J; Kanz L; Einhorn L; Bokemeyer C
Ann Oncol; 2002 Jul; 13(7):1017-28. PubMed ID: 12176779
[TBL] [Abstract][Full Text] [Related]
18. [Clinical analysis of primary mediastinal germ cell tumors].
Zhou JF; Bai CM; Yang D; Chen SC
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):531-4. PubMed ID: 18069635
[TBL] [Abstract][Full Text] [Related]
19. Primary mediastinal and retroperitoneal malignant germ cell tumors in children and adolescents: Results of the TGM95 trial, a study of the French Society of Pediatric Oncology (Société Française des Cancers de l'Enfant).
Sudour-Bonnange H; Faure-Conter C; Martelli H; Hameury F; Fresneau B; Orbach D; Vérité C
Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28306215
[TBL] [Abstract][Full Text] [Related]
20. Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.
Funt SA; Patil S; Feldman DR; Motzer RJ; Bajorin DF; Sheinfeld J; Tickoo SK; Reuter VE; Bosl GJ
J Clin Oncol; 2019 Sep; 37(26):2329-2337. PubMed ID: 31233353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
